This study compared the expression of the genes encoding human leucocyte antigens (HLA)-A, -B, -DP, -DR and -G in peripheral blood mononuclear cells (PBMCs) in gastric cancer patients and healthy controls. Using reverse transcriptionpolymerase chain reaction, levels of classical HLA-A, -B, -DP and -DR and nonclassical HLA-G mRNA were studied in 43 gastric cancer patients and 22 controls. In addition, the levels of HLA-A,B,C and -G antigens on the surface of PBMCs were measured in 30 gastric cancer patients and 15 controls using flow cytometry. The mean fluorescence intensity of HLA-A,B,C antigen in the gastric cancer group was significantly lower than in controls. The HLA-G antigen was mainly present on CD4 + CD8 -T-lymphocytes. The percentage of CD4 + CD8 -T-lymphocytes positive for HLA-G antigen was significantly lower in the gastric cancer group compared with the healthy controls. Levels of HLA-A, -B and -G mRNA in the gastric cancer group were significantly lower than in controls. The HLA-G mRNA levels were significantly lower in gastric cancer of histological grades III and IV than in grades I and II. These data may provide a novel diagnostic and research tool for gastric cancer.
Introduction
Major histocompatibility complex (MHC) antigens serve as signals to direct T-cellmediated immune responses. Among the tumour immune escape mechanisms described to date, alterations in the expression of MHC molecules play a crucial role in tumour development due to the role of MHC antigens in antigen presentation to T-lymphocytes and the regulation of natural killer (NK) cell function. 1 -6 Because of the low levels or even absence of MHC antigens on tumour cells, T-cell receptors are unable to recognize them. Weak expression of MHC genes on tumour cells is associated with increased malignancy and metastasis, and a poorer prognosis. 7 Plaksin et al. 8 found that the highly metastatic clones of the murine 3LL carcinoma can induce the up-regulation of Y Zhang, Y Liu, N Lu et al. Expression of genes encoding HLA in gastric cancer mouse H-2K b MHC class I antigen by transfecting the H-2K b gene into the 3LL cell. They suggested that the abnormal variation in mouse MHC antigen was the key factor affecting tumour metastasis. MHC class I antigens are plentiful on peripheral blood mononuclear cells (PBMCs), but their clinical significance in tumour progression is unclear.
In the present study, the expression of the genes encoding human leucocyte antigens (HLA)-A, -B, -DR and -DP and non-classical HLA-G as shown by mRNA levels, and the protein levels for HLA-A,B,C and HLA-G antigens were measured in PBMCs from gastric cancer patients and healthy controls using real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) and flow cytometry, respectively.
Patients and methods

PATIENTS
Patients with a histopathological diagnosis of cancer who were attending the Qilu Hospital of Shandong University, Jinan, China, for treatment between October 2008 and May 2009 were enrolled sequentially into the study. None of the patients included in the study had received prior chemotherapy. Heparinized venous peripheral blood samples were collected from patients and volunteers. The study protocol was approved by the Human Investigations Committee of Qilu Hospital of Shandong University and written informed consent was obtained from all the study participants or their relatives.
ISOLATION OF RNA FROM PBMCs
The PBMCs were isolated from heparinized blood samples by gradient centrifugation using Ficoll-Paque (Pharmacia Diagnostics, Uppsala, Sweden). Briefly, 2 ml heparinized blood was pipetted into 7-ml test tubes and diluted 1:1 in phosphate-buffered saline (PBS), giving a total volume of 4 ml. This was then carefully layered over 4 ml of a Ficoll-Paque gradient in 12-ml centrifuge tubes (8 ml/tube) and the tubes were centrifuged for 15 min at 1500 g. The cell interface layer was harvested carefully and the cells were washed twice in PBS (for 10 min at 750 g followed by 10 min at 500 g). The PBMC pellets were then frozen at -80°C, within 4 h from blood collection. For RNA extraction, the purified PBMCs were then applied to an RNeasy minicolumn (Qiagen, Hilden, Germany) and processed according to the manufacturer's instructions. Total RNA was eluted with 15 µl of RNase-free water and stored at -80°C. The amount of RNA was determined using an Eppendorf Biophotometer (Brinkmann Instruments, Westbury, NY, USA) and normalized to 1 µg/ml for each real-time quantitative RT-PCR sample.
REAL-TIME QUANTITATIVE RT-PCR
Multiplex real-time RT-PCR was performed for HLA-A, -B, -DP, -DR and -G on a ABI PRISM ® 7500 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) using SYBR ® Green (Toyobo, Osaka, Japan) as a double-strand DNA-specific binding dye; β-actin was used as an endogenous control. Amplification was carried out in a total volume of 20 µl, consisting of 10 µl of diethylpyrocarbonate water, 4 µl of 5× RT buffer (250 mM Tris-HCl [pH 8.3], 375 mM potassium chloride, 15 mM magnesium chloride, 50 mM dithiothreitol), 1 µl of oligonucleotide primer, 1 µl of 0.5 mmol/l deoxynucleotide triphosphate, 1 µl of 10 U/l reverse transcriptase and 3 µl of RNA template. All the amplification primers used were intron-spanning; their sequences are listed in Table 1 .
The amplification conditions were: initial denaturation at 95°C for 1 min, followed by 40 consecutive cycles of denaturation at 95°C for 15 s, annealing at 60°C for 15 s and Y Zhang, Y Liu, N Lu et al.
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extension at 72°C for 45 s. Melting curve analysis was performed after completing the amplification, at 95°C for 15 s, 60°C for 1 min, 95°C for 15 s and 60°C for 15 s. The specificity of the product was evaluated using 2% agarose gel electrophoresis and visualization under UV light. The cycle number at which the threshold line intersected the linear curve for each sample was used to determine the threshold cycle (C T ) value, and the relative values of gene amplification were calculated using the formula 2 -ΔΔCT . 9
FLOW CYTOMETRY
The PBMCs isolated from heparinized blood samples by gradient centrifugation, as described above, were incubated with saturating levels (10 µl) of phycoerythrin (PE)-labelled anti-HLA-A,B,C and anti-HLA-G antibodies and fluorescein isothiocyanatelabelled anti-CD4 and anti-CD8 monoclonal antibodies (Becton Dickinson, Franklin Lakes, NJ, USA) for 30 min at 37°C. Stained cells were then washed twice in the sheath fluid and re-suspended in 0.1 mM phosphatebuffered saline (PBS), pH 7.4, containing 1% formaldehyde and 0.5% sodium azide. Surface immunofluorescence was detected using FACScan™ flow cytometry (Becton Dickinson). Non-specific binding was subtracted using PE-labelled mouse antiimmunoglobulin (Ig)G2a (eBioscience, San Diego, CA, USA). Data were analysed using FCS Express, version 3.0 (De Novo Software, Thornhill, Ontario, Canada).
STATISTICAL ANALYSIS
All data were analysed using the SPSS ® statistical package, version 10.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Differences between the groups were analysed using the χ 2 or rank sum tests. All P-values were twotailed and a P-value < 0.05 was considered to be statistically significant.
Results
A total of 43 newly diagnosed gastric cancer patients (34 males and nine females, age range 25 -79 years, median age 55.8 years) were included in the study. Of these, 10 had well-and moderately-differentiated cancer, including mastoid adenocarcinomas and tubular adenocarcinoma, and 33 had poorly The PBMCs from an additional 18 healthy volunteers were mixed together and used for calibration in the semi-quantitative analysis.
Levels of HLA-A, -B, -DP, -DR and -G mRNA in PBMCs were measured in all 43 gastric cancer patients and 22 healthy controls. The HLA-A, -B and -G mRNA levels were significantly lower in the gastric cancer group compared with the healthy controls (P < 0.01), whereas there was no significant difference in HLA-DP and -DR mRNA levels between the two groups (Table 2, Fig. 1 ). There was no correlation between the levels of HLA-A, -B and -G mRNA and the clinical stage of gastric cancer; however, HLA-G mRNA levels were significantly lower in patients with histological grades III and IV than in those with histological grades I and II (P < 0.05) ( Table 2) .
Protein levels of the HLA-A,B,C and HLA-G antigens on PBMCs were measured using flow cytometry in the 30 gastric cancer patients and 15 healthy controls which expressed mRNA differently. The percentage of cells positive for HLA-A,B,C antigen was similar in the gastric cancer group and healthy controls; however, the mean fluorescence intensity of the two groups was significantly different (P < 0.05; Table 3 , Fig.  2) . The HLA-G molecule was mainly present on CD4 + CD8 -T-lymphocytes. The percentage of CD4 + CD8 -T-lymphocytes positive for HLA-G antigen was significantly lower in the gastric cancer group compared with the healthy controls (P < 0.05) ( Table 3 , Fig. 3 ). 
Discussion
The MHC comprises a large genomic region or gene family found in most vertebrates and is the most gene-dense region of the mammalian genome. It plays an important role in the immune system and autoimmunity and, in humans, the genes involved in immunity are the HLA genes; HLA-A, -B, -DP and -DR are termed the classical MHC genes. The HLA-G antigen is a nonclassical MHC class I molecule with highly limited tissue distribution that is thought to have mainly immunoregulatory functions. 10 It is well known that MHC gene expression is regulated during malignancy. 11 Although the changes in MHC expression in PBMCs in 12 -14 Le Morvan et al. 15 demonstrated a significant decrease in HLA-A and -B mRNA levels in peripheral lymphocytes with increasing age using a competitive RT-PCR method, which is consistent with the weakening of the immune system that accompanies old age. Studies on varicella-zoster virus (VZV) pathogenesis demonstrated that cell surface MHC class I was down-regulated specifically on VZVinfected human CD3 + T-lymphocytes. 16, 17 It has been shown that NK cells recognize and kill cellular targets and produce proinflammatory cytokines, and these functions can be controlled by inhibitory receptors for the polymorphic MHC class I molecules. 18, 19 Inhibitory receptors are not, however, uniformly expressed on NK cells and are germline-encoded by a set of polymorphic genes that segregate independently from MHC genes. 20, 21 Thus, NK cells acquire functional competence through 'licensing' by self-MHC molecules. 22 Previous work has reported that HLA-B was down-regulated in PBMCs in gastric cancer patients. 23 The present study showed that HLA-A, -B and -G mRNA levels in PBMCs from gastric cancer patients were significantly lower than those from healthy controls. Although the mechanism and function involved in the down-regulation of HLA-A, -B and -G genes are not clear, it would appear that the expression of HLA-A and -B is correlated with host immune status. Downregulation of HLA class I molecules can lead to reduced immune function and lethal effect on the cells. In vitro RNA interference studies have demonstrated that inhibition of MHC expression may reduce the power of lymphocytes to kill tumour cells. 22 Thus, the down-regulation of MHC class I may influence host immune function and enable tumour cells to evade immune recognition.
HLA-G may inhibit the function of NK cells and cytotoxic T-lymphocytes and is often overexpressed in tumour cells. 24 Over-expression of HLA-G can activate inhibitory receptors and contribute to the immune evasion of tumour cells. 25 There is, however, little research on the expression of HLA-G in PBMCs. The present study indicated that HLA-G mRNA levels in PBMCs in gastric cancer patients, especially those of histological grades III and IV, was much lower than in healthy controls. This suggests that down-regulation of HLA-G in PBMCs may be related to tumour development, although the mechanism requires further study. The present study also showed that there was no significant difference in terms of HLA-DP and -DR mRNA levels in PBMCs between gastric cancer patients and healthy controls. This may be because the antitumour immune response is primarily cellular, whereas HLA-DP and -DR are mainly expressed on B-cells, macrophages and dendritic cells, which are closely correlated with the humoral immune response.
In conclusion, the present study indicates that the mRNA levels of HLA-A, -B and -G in PBMCs may provide reference values for the clinical diagnosis and monitoring of intervention in gastric cancer. The use of RT-PCR to detect HLA-A, -B and -G mRNA may provide a novel experimental tool for further study.
